Leflunomide
Leflunomide is a generic prescription drug classified as an antirheumatic agent. It is available in oral tablet form with strengths of 10mg and 20mg, used to manage inflammatory conditions like rheumatoid arthritis. Manufactured by Heritage Pharmaceuticals and others under ANDA077086. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Leflunomide is a generic prescription drug classified as an antirheumatic agent. It is available in oral tablet form with strengths of 10mg and 20mg, used to manage inflammatory conditions like rheumatoid arthritis. Manufactured by Heritage Pharmaceuticals and others under ANDA077086. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Leflunomide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Leflunomide — ANDA 077086 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077086"
}
]
|
| identifier | ANDA077086 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Leflunomide |
